248 related articles for article (PubMed ID: 35387387)
21. Comparative Risk of Major Congenital Malformations With 8 Different Antiepileptic Drugs: A Prospective Cohort Study of the EURAP Registry.
Vossler DG
Epilepsy Curr; 2019; 19(2):83-85. PubMed ID: 30955418
[TBL] [Abstract][Full Text] [Related]
22. Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM.
Pack AM; Oskoui M; Williams Roberson S; Donley DK; French J; Gerard EE; Gloss D; Miller WR; Munger Clary HM; Osmundson SS; McFadden B; Parratt K; Pennell PB; Saade G; Smith DB; Sullivan K; Thomas SV; Tomson T; Dolan O'Brien M; Botchway-Doe K; Silsbee HM; Keezer MR
Neurology; 2024 Jun; 102(11):e209279. PubMed ID: 38748979
[TBL] [Abstract][Full Text] [Related]
23. Adherence to and persistence with lacosamide, perampanel, lamotrigine, and levetiracetam in adult patients with focal epilepsy in Japan: A descriptive cohort study using a claims database.
Chen S; Fukasawa T; Ikeda A; Takeuchi M; Shimotake A; Yoshida S; Kawakami K
Heliyon; 2023 Apr; 9(4):e15017. PubMed ID: 37064469
[TBL] [Abstract][Full Text] [Related]
24. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
Yu L; Feng J; Yu Z; Dai H
Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644
[TBL] [Abstract][Full Text] [Related]
25. Association of Prenatal Exposure to Antiseizure Medications With Creative and Executive Function at Age 4.5 Years.
Meador KJ; Cohen MJ; Loring DW; Matthews AG; Brown CA; Robalino C; Carmack A; Sumners S; Birnbaum AK; Kalayjian LA; Gedzelman E; Voinescu PE; Gerard EE; Hanna J; Cavitt J; Sam M; Hwang ST; Pack AM; Tsai JJ; Pennell PB;
Neurology; 2024 Jun; 102(12):e209448. PubMed ID: 38810172
[TBL] [Abstract][Full Text] [Related]
26. Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine.
Deshmukh U; Adams J; Macklin EA; Dhillon R; McCarthy KD; Dworetzky B; Klein A; Holmes LB
Neurotoxicol Teratol; 2016; 54():5-14. PubMed ID: 26791321
[TBL] [Abstract][Full Text] [Related]
27. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
Terman SW; Youngerman BE; Choi H; Burke JF
Epilepsia; 2022 Jun; 63(6):1571-1579. PubMed ID: 35294775
[TBL] [Abstract][Full Text] [Related]
28. Patterns of antiseizure medication prescription in pregnancy and maternal complications in women with epilepsy: A retrospective study in Saudi Arabia.
Alsfouk BA; Almarzouqi MR; Alageel S; Alsfouk AA; Alsemari A
Saudi Pharm J; 2022 Mar; 30(3):205-211. PubMed ID: 35498221
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
[TBL] [Abstract][Full Text] [Related]
30. Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide.
Nucera B; Brigo F; Trinka E; Kalss G
Ther Adv Neurol Disord; 2022; 15():17562864221101687. PubMed ID: 35706844
[TBL] [Abstract][Full Text] [Related]
31. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.
Veroniki AA; Rios P; Cogo E; Straus SE; Finkelstein Y; Kealey R; Reynen E; Soobiah C; Thavorn K; Hutton B; Hemmelgarn BR; Yazdi F; D'Souza J; MacDonald H; Tricco AC
BMJ Open; 2017 Jul; 7(7):e017248. PubMed ID: 28729328
[TBL] [Abstract][Full Text] [Related]
32. Neurodevelopmental effects of fetal antiepileptic drug exposure.
Velez-Ruiz NJ; Meador KJ
Drug Saf; 2015 Mar; 38(3):271-8. PubMed ID: 25693658
[TBL] [Abstract][Full Text] [Related]
33. Neurodevelopment Following Exposure to Antiseizure Medications in Utero: A Review.
Bromley RL; Bluett-Duncan M
Curr Neuropharmacol; 2021; 19(11):1825-1834. PubMed ID: 34279202
[TBL] [Abstract][Full Text] [Related]
34. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.
Bromley R; Weston J; Adab N; Greenhalgh J; Sanniti A; McKay AJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010236. PubMed ID: 25354543
[TBL] [Abstract][Full Text] [Related]
35. Effects of antiseizure medications on placental cells: Focus on heterodimeric placental carriers.
Tetro N; Hamed R; Berman E; Eyal S
Epilepsy Res; 2021 Aug; 174():106664. PubMed ID: 34022522
[TBL] [Abstract][Full Text] [Related]
36. Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS).
Kamitaki BK; Minacapelli CD; Zhang P; Wachuku C; Gupta K; Catalano C; Rustgi V
Epilepsy Behav; 2021 Apr; 117():107832. PubMed ID: 33626490
[TBL] [Abstract][Full Text] [Related]
37. Neurodevelopment of babies born to mothers with epilepsy: A prospective observational cohort study.
Bromley RL; Bullen P; Campbell E; Craig J; Ingham A; Irwin B; Jackson C; Kelly T; Morrow J; Rushton S; García-Fiñana M; Hughes DM; Winterbottom J; Wood A; Yates LM; Clayton-Smith J;
Epilepsia; 2023 Sep; 64(9):2454-2471. PubMed ID: 37403560
[TBL] [Abstract][Full Text] [Related]
38. Antiseizure medications use during pregnancy and congenital malformations: A retrospective study in Saudi Arabia.
Alsfouk BA; Almarzouqi MR; Alsfouk AA; Alageel S; Alsemari A
Saudi Pharm J; 2021 Sep; 29(9):939-945. PubMed ID: 34588839
[TBL] [Abstract][Full Text] [Related]
39. The impact of pregnancy on the pharmacokinetics of antiseizure medications: A systematic review and meta-analysis of data from 674 pregnancies.
Schoretsanitis G; Deligiannidis KM; Kasperk N; Schmidt CT; Kittel-Schneider S; Ter Horst P; Berlin M; Kohn E; Poels EMP; Zutshi D; Tomson T; Spigset O; Paulzen M
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jul; 133():111030. PubMed ID: 38762161
[TBL] [Abstract][Full Text] [Related]
40. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.
Meador KJ; Baker GA; Browning N; Cohen MJ; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
Lancet Neurol; 2013 Mar; 12(3):244-52. PubMed ID: 23352199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
